Dynamic Technology Lab’s Arcturus Therapeutics ARCT Stock Holding History

Dynamic Technology Lab’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$102K	Buy	+15,177	New	+$120K	0.02%	594
2025 Q2	–	Sell	-28,257	Closed	-$299K	–	926
2025 Q1	$299K	Buy	+28,257	New	+$449K	0.04%	709
2023 Q1	–	Sell	-12,193	Closed	-$207K	–	1073
2022 Q4	$207K	Buy	+12,193	New	+$213K	0.02%	903
2022 Q3	–	Sell	-35,030	Closed	-$551K	–	1109
2022 Q2	$551K	Buy	+35,030	New	+$687K	0.06%	537
2021 Q2	–	Sell	-9,520	Closed	-$393K	–	1114
2021 Q1	$393K	Buy	+9,520	New	+$567K	0.04%	683
2016 Q1	–	Sell	-1,561	Closed	-$69K	–	898
2015 Q4	$69K	Buy	+1,561	New	+$70.3K	0.02%	824

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dynamic Technology Lab's ARCT Position: Q2 2026 in Review

Dynamic Technology Lab opened a new position in Arcturus Therapeutics (ARCT) in Q2 2026: 15,177 shares worth $102K. The stake represents 0.02% of the portfolio and ranks #594 among its holdings. This is a return to the name: Dynamic Technology Lab previously reported a position in ARCT as recently as Q1 2025.

Dynamic Technology Lab first reported a position in ARCT in Q4 2015 and has held it in 6 quarters since. The position peaked at $551K in Q2 2022. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

Dynamic Technology Lab held 15,177 shares of Arcturus Therapeutics worth $102K as of Q2 2026.
Arcturus Therapeutics was a new Dynamic Technology Lab position in Q2 2026.
Arcturus Therapeutics made up 0.02% of Dynamic Technology Lab's portfolio in Q2 2026, its #594 holding.
Dynamic Technology Lab first reported a position in Arcturus Therapeutics in Q4 2015 and has held it in 6 quarters since.
Dynamic Technology Lab's Arcturus Therapeutics position peaked at $551K in Q2 2022.
135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.